1. Neumonía neumocócica en la era de la vacuna conjugada heptavalente
- Author
-
Maria del Carmen Gallegos, Carlos José Alonso-Villaverde, David Beingolea, Aroa Villoslada, Antoni Payeras, Mercedes García-Gasalla, Antonio Pareja, Margarita Garau, and María Borras
- Subjects
Microbiology (medical) ,medicine.medical_specialty ,business.industry ,Emergency department ,medicine.disease ,medicine.disease_cause ,Pneumococcal conjugate vaccine ,Surgery ,Pneumonia ,Community-acquired pneumonia ,Internal medicine ,Streptococcus pneumoniae ,Pneumococcal pneumonia ,medicine ,Heptavalent Pneumococcal Conjugate Vaccine ,Prospective cohort study ,business ,medicine.drug - Abstract
Introduction: To describe clinical features, complications, serotypes and antibiotic resistance in pneumococcal pneumonia in our environment after the generalization of the heptavalent conjugate vaccine (PCV-7) in paediatrics. Material and methods: Prospective study of episodes of pneumococcal pneumonia, with positive cultures in patients treated in the emergency department from January 2006 to February 2010. Results: We studied 346 episodes in 320 patients, 335 belonged to 309 adult patients, 221 (71.5%) males, median age 68 years (range 16-94), and 11 episodes to patients < 15 years. Two-hundred and thirty seven (68.5%) episodes were community acquired. Bacteraemia was present in 130 (37.6%) cases, with a tendency towards an increased risk in patients < 65 years (OR = 1.56, 95% CI 0.96- 2.56, P = .07). Thirteen
- Published
- 2011
- Full Text
- View/download PDF